Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

NCT01402544 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Per study sponsor decision.

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: ranibizumab

Sponsor

University of California, San Diego

Collaborators

[object Object]